The FDA's vaccine advisory committee meeting come less than a month after U.S. regulators authorized third Covid shots of Pfizer's vaccine.
The FDA advisory group is scheduled Thursday to discuss data on the safety and effectiveness of a Moderna booster shot in adults. On Friday, the committee is expected to debate J&J booster shots for adults. The FDA could make a final decision within days of the meetings, handing it off to the CDC and its vaccine advisory committee to make their own decision.
The strain led to a surge in hospitalizations in the U.S., mainly among the unvaccinated. Still, some vaccinated Americans have suffered so-called breakthrough infections and just over 19,000 of them – less than 1% – have been hospitalized or died with Covid as of Sept. 20, according to data compiled by the CDC.
J&J said last month a second dose of its single-shot vaccine was safe and boosted protection against symptomatic infection from around 70% to 94% when administered two months after the first dose in the United States. Committee members will have to debate whether its safe and effective for J&J recipients to get a second dose, Baylor said. He added he doesn't expect any trouble authorizing third doses of Moderna's vaccine as it uses mRNA technology, which was also used to develop Pfizer's vaccines.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Covid-19: Three more Covid-related deaths and 1,115 new casesThe total number of coronavirus-linked deaths in NI since the start of the pandemic is 2,588.
Baca lebih lajut »
Covid-19: NHS Covid passes, and lockdown lifted in SydneyFive things you need to know about the coronavirus pandemic this Monday morning.
Baca lebih lajut »
Moderna, Racing for Profits, Keeps COVID Vaccine Out of Reach of PoorModerna, whose coronavirus vaccine appears to be the world’s best defense against COVID-19, has been supplying its shots almost exclusively to wealthy nations, keeping poorer countries waiting and earning billions in profit. After developing a breakthrough vaccine with the financial and scientific support of the U.S. government, Moderna has shipped a greater share of its doses to wealthy countries than any other vaccine manufacturer, according to Airfinity, a data firm that tracks vaccine shipme
Baca lebih lajut »
Primero COVID-19, ahora VIH: Científicos de Moderna y San Diego trabajan para crear una vacunaLos investigadores planean utilizar una serie de inyecciones para enseñar al sistema inmunitario a producir respuestas de anticuerpos contra el virus
Baca lebih lajut »
Merck asks the FDA to authorize use of its promising COVID-19 pillDrugmaker Merck has asked U.S. regulators to authorize its promising pill protecting against COVID-19, setting the stage for a decision within weeks.
Baca lebih lajut »
Merck asks FDA for emergency authorization for experimental Covid pillIf cleared by the Food and Drug Administration — a decision that could come in a matter of weeks — it would be the first pill shown to treat Covid-19.
Baca lebih lajut »